Bailey Gregory
SEC insider (Form 3/4/5 filer). CIK 0001329505. Director at Serina Therapeutics, Inc. (SER) and 1 other issuer. 15 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in HUNTSVILLE, AL.
Companies Bailey Gregory has filed insider reports for
- Serina Therapeutics, Inc. (SER): Director
- Biohaven Ltd. (BHVN): Director
Bailey Gregory
CIK: 0001329505
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Jun 17, 2026SER
Serina Therapeutics, Inc.
AwardDirectStock Option (right to buy)
15.3K shares- - Jun 17, 2026SER
Serina Therapeutics, Inc.
ConversionDirect1.8M shares at avg. $2.25$4.0M - Jun 17, 2026SER
Serina Therapeutics, Inc.
ConversionDirect6.7M shares at avg. $2.25$15.0M - Jun 17, 2026SER
Serina Therapeutics, Inc.
AwardDirectRedeemable Warrants
3.3M shares- - Apr 28, 2026BHVN
Biohaven Ltd.
AwardDirectStock Options (Right to buy)
68.7K shares- - Mar 31, 2026SER
Serina Therapeutics, Inc.
AwardDirect59.7K shares at avg. $1.94$116K - Nov 13, 2025BHVN
Biohaven Ltd.
PurchaseDirect400K shares at avg. $7.50$3.0M - Nov 7, 2025SER
Serina Therapeutics, Inc.
AwardDirectStock Option (right to buy)
10K shares- - May 5, 2025BHVN
Biohaven Ltd.
AwardDirectStock Options (Right to buy)
31.7K shares- - Apr 8, 2025SER
Serina Therapeutics, Inc.
AwardDirectSeries A Convertible Preferred Stock
762.5K shares at avg. $5.18-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  SER Serina Therapeutics, Inc. | Award Stock Option (right to buy) | 15,250 | - | - | Direct |
| Jun 17, 2026 | SER Serina Therapeutics, Inc. | Conversion | 1,770,805 | $2.25 | $3,984,311 | Direct |
| Jun 17, 2026 | SER Serina Therapeutics, Inc. | Conversion | 6,666,667 | $2.25 | $14,999,334 | Direct |
| Jun 17, 2026 | SER Serina Therapeutics, Inc. | Award Redeemable Warrants | 3,333,333 | - | - | Direct |
| Apr 28, 2026 |  BHVN Biohaven Ltd. | Award Stock Options (Right to buy) | 68,693 | - | - | Direct |
| Mar 31, 2026 | SER Serina Therapeutics, Inc. | Award | 59,667 | $1.94 | $115,754 | Direct |
| Nov 13, 2025 | BHVN Biohaven Ltd. | Purchase | 400,000 | $7.50 | $3,000,000 | Direct |
| Nov 7, 2025 | SER Serina Therapeutics, Inc. | Award Stock Option (right to buy) | 10,000 | - | - | Direct |
| May 5, 2025 | BHVN Biohaven Ltd. | Award Stock Options (Right to buy) | 31,716 | - | - | Direct |
| Apr 8, 2025 | SER Serina Therapeutics, Inc. | Award Series A Convertible Preferred Stock | 762,548 | $5.18 | - | Direct |
1-10 of 15 transactions